EX-10.19 6 filename6.htm *** CONFIDENTIAL TREATMENT REQUESTED. Confidential portions of this document have been redacted and have been separately filed with the Commission. PATHOLOGY SERVICES AGREEMENTPathology Services Agreement • May 5th, 2020 • Texas
THIS PATHOLOGY SERVICES AGREEMENT (“Agreement”) is made this 12th day of November, 2010 (the “Effective Date”), by and among VERACYTE, INC., a California corporation (“Veracyte”), and BRAZOS VALLEY PATHOLOGY, P.A. D/B/A REITPATH, a Texas professional association (“Pathologists”). Veracyte and Pathologists are sometimes referred to in this Agreement as a “Party” or, collectively, as the “Parties.”
FIRST AMENDMENT TO PATHOLOGY SERVICES AGREEMENTPathology Services Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories
THIS FIRST AMENDMENT TO PATHOLOGY SERVICES AGREEMENT (the “Amendment”) is made and entered into as of December 19, 2012, by and between VERACYTE, INC., a California corporation (“Veracyte”) and THYROID CYTOLOGY PARTNERS, P.A., a Texas professional association (“Pathologists”) with respect to the following:
APPROVAL OF VERACYTE, INC.Pathology Services Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories
Reference is made to that certain Pathology Services Agreement (the “Contract”) dated November 12, 2010 by and among Veracyte, Inc. (“Veracyte”) and Brazos Valley Pathology, P.A. (“BVPPA”). As of May 18, 2011, Veracyte hereby consents to the assignment of the Contract from BVPPA to Thyroid Cytopathology Partners, P.A. (“TCP”) as provided in that certain Assignment of Contract dated Dec 2, 2010.
AMENDED AND RESTATED PATHOLOGY SERVICES AGREEMENTPathology Services Agreement • July 31st, 2017 • Precipio, Inc. • Laboratory analytical instruments • Connecticut
This PATHOLOGY SERVICES AGREEMENT (“Agreement”) is made and entered into on the 21st day of March, 2017 with an effective date of the renewal on June 1, 2016 (“Effective Date”), by and between YALE UNIVERSITY, a Connecticut domestic non-stock corporation, acting in behalf of its School of Medicine, Department of Pathology of its School of Medicine (“Yale”), and PRECIPIO DIAGNOSTICS, LLC., and Precipio Diagnostics, Inc., both Delaware corporations, collectively (“Precipio”). Yale and Precipio sometimes are referred to herein collectively as the “Parties” and individually as a “Party.”
AMENDED AND RESTATED PATHOLOGY SERVICES AGREEMENTPathology Services Agreement • April 30th, 2019 • Veracyte, Inc. • Services-medical laboratories • Texas
This Business Associate Agreement (the “Agreement”) is made by and among VERACYTE, INC., a California corporation (herein referred to as “Covered Entity”) and THYROID CYTOPATHOLOGY PARTNERS, P.A., a Texas professional association (hereinafter referred to as “Business Associate”). Covered Entity and Business Associate shall be collectively referred to herein as the “Parties”.
SECOND AMENDMENT TO PATHOLOGY SERVICES AGREEMENTPathology Services Agreement • March 20th, 2014 • Veracyte, Inc. • Services-medical laboratories
THIS SECOND AMENDMENT TO PATHOLOGY SERVICES AGREEMENT (this “Amendment”) is made and entered into as of January 1, 2014, by and between VERACYTE, INC. (“Veracyte”) and THYROID CYTOPATHOLOGY PARTNERS, P.A. (“Pathologists”).
